The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective
Open accessAbstract
SUMMARY: Streptococcus pneumoniae inflicts a huge disease burden as the leading cause of community-acquired pneumonia and meningitis. Soon after mainstream antibiotic usage, multiresistant pneumococcal clones emerged and disseminated worldwide. Resistant clones are generated through adaptation to antibiotic pressures imposed while naturally residing within the human upper respiratory tract. Here, a huge array of related commensal streptococcal strains transfers core genomic and accessory resistance determinants to the highly transformable pneumococcus. β-Lactam resistance is the hallmark of pneumococcal adaptability, requiring multiple independent recombination events that are traceable to nonpneumococcal origins and stably perpetuated in multiresistant clonal complexes. Pneumococcal strains with elevated MICs of β-lactams are most often resistant to additional antibiotics. Basic underlying mechanisms of most pneumococcal resistances have been identified, although new insights that increase our understanding are continually provided. Although all pneumococcal infections can be successfully treated with antibiotics, the available choices are limited for some strains. Invasive pneumococcal disease data compiled during 1998 to 2013 through the population-based Active Bacterial Core surveillance program (U.S. population base of 30,600,000) demonstrate that targeting prevalent capsular serotypes with conjugate vaccines (7-valent and 13-valent vaccines implemented in 2000 and 2010, respectively) is extremely effective in reducing resistant infections. Nonetheless, resistant non-vaccine-serotype clones continue to emerge and expand.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Global, regional, and national causes of child mortality in 2008: a systematic analysis
Black, R. E., Cousens, S., Johnson, H. L., Lawn, J. E., Rudan, I., Bassani, D. G., Jha, P., Campbell, H., Walker, C. F., Cibulskis, R., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60549-1 · Cited by 3,058
STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES
Avery, O. T., MacLeod, C. M., & McCarty, M. (1944) · Journal of Experimental Medicine · doi:10.1084/jem.79.2.137 · Cited by 2,683
Antibiotic resistance and its cost: is it possible to reverse resistance?
Andersson, D. I., & Hughes, D. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2319 · Cited by 2,294
Surveillance for waterborne-disease outbreaks--United States, 1993-1994.
Kramer, M. H., Herwaldt, B. L., Craun, G. F., Calderon, R. L., & Juranek, D. D. (1996) · PubMed · Cited by 2,152
Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement
Cockerill, F. R., & Clinical (2008) · Medical Entomology and Zoology · Cited by 2,065
ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes
Gupta, S. K., Padmanabhan, B. R., Diene, S. M., Lopez-Rojas, R., Kempf, M., Landraud, L., & Rolain, J.-M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01310-13 · Cited by 1,476
The Significance of Pneumococcal Types
Griffith, F. (1928) · Journal of Hygiene · doi:10.1017/s0022172400031879 · Cited by 1,344
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Pilishvili, T., Lexau, C., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Reingold, A., Thomas, A., Schaffner, W., Craig, A. S., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/648593 · Cited by 1,311
Self-citationHoltzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110
Klugman, K. P., Madhi, S. A., Huebner, R. E., Kohberger, R., Mbelle, N., & Pierce, N. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035060 · Cited by 1,009
Tipper, D. J., & Strominger, J. L. (1965) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.54.4.1133 · Cited by 1,008 · cited 1×
“Binding of -lactams to the transpeptidase active site of these penicillinbinding proteins (PBPs) thus blocks cross-linking of muropeptide chains to prevent cell wall synthesis (92).”
BackgroundErythromycin resistance by ribosome modification
Weisblum, B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.577 · Cited by 1,008
Mandell, L. A., Bartlett, J. G., Dowell, S. F., File, T. M., Musher, D. M., & Whitney, C. (2003) · Clinical Infectious Diseases · doi:10.1086/380488 · Cited by 1,004
(1997) · PsycEXTRA Dataset · doi:10.1037/e547512006-001 · Cited by 1,000
Rapid Pneumococcal Evolution in Response to Clinical Interventions
Croucher, N. J., Harris, S. R., Fraser, C., Quail, M. A., Burton, J., van der Linden, M., McGee, L., von Gottberg, A., Song, J. H., Ko, K. S., et al. (2011) · Science · doi:10.1126/science.1198545 · Cited by 886
Self-citationKyaw, M. H., Lynfield, R., Schaffner, W., Craig, A. S., Hadler, J., Reingold, A., Thomas, A. R., Harrison, L. H., Bennett, N. M., Farley, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051642 · Cited by 881
The biological cost of antibiotic resistance
Andersson, D. I., & Levin, B. R. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)00005-3 · Cited by 867
Pneumococcal resistance to antibiotics
Klugman, K. P. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.2.171 · Cited by 799
Gray, B. M., Converse, G. M., & Dillon, H. C. (1980) · Journal of Infectious Diseases · doi:10.1093/infdis/142.6.923 · Cited by 796
Moore, M. R., Link-Gelles, R., Schaffner, W., Lynfield, R., Lexau, C., Bennett, N. M., Petit, S., Zansky, S. M., Harrison, L. H., Reingold, A., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)71081-3 · Cited by 733
Self-citationEmergence of Multiply Resistant Pneumococci
Jacobs, M. R., Koornhof, H. J., Robins-Browne, R. M., Stevenson, C. M., Vermaak, Z. A., Freiman, I., Miller, G. B., Witcomb, M. A., Isaäcson, M., Ward, J. I., et al. (1978) · New England Journal of Medicine · doi:10.1056/nejm197810052991402 · Cited by 630
Whitney, C. G., Pilishvili, T., Farley, M. M., Schaffner, W., Craig, A. S., Lynfield, R., Nyquist, A.-C., Gershman, K. A., Vazquez, M., Bennett, N. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69637-2 · Cited by 623
Self-citationMortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.2.223 · Cited by 589
Carvalho, M. D. G. S., Tondella, M. L., McCaustland, K., Weidlich, L., McGee, L., Mayer, L. W., Steigerwalt, A., Whaley, M., Facklam, R. R., Fields, B., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02498-06 · Cited by 588
Self-citationGuillemot, D., Carbon, C., Balkau, B., Geslin, P., Lecoeur, H., Vauzelle-Kervroëdan, F., Bouvenot, G., & Eschwége, E. (1998) · JAMA · doi:10.1001/jama.279.5.365 · Cited by 545
Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia
Davidson, R., Cavalcanti, R., Brunton, J. L., Bast, D. J., de Azavedo, J. C. S., Kibsey, P., Fleming, C., & Low, D. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012122 · Cited by 533
McGee, L., McDougal, L., Zhou, J., Spratt, B. G., Tenover, F. C., George, R., Hakenbeck, R., Hryniewicz, W., Lefévre, J. C., Tomasz, A., et al. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.7.2565-2571.2001 · Cited by 518
Self-citationThe Prevalence of Drug-Resistant Streptococcus pneumoniae In Atlanta
Hofmann, J., Cetron, M. S., Farley, M. M., Baughman, W. S., Facklam, R. R., Elliott, J. A., Deaver, K. A., & Breiman, R. F. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508243330803 · Cited by 503
Relationship between Nasopharyngeal Colonization and the Development of Otitis Media in Children
Faden, H., Duffy, L., Wasielewski, R., Wolf, J., Krystofik, D., Tung, Y., & Pediatrics, T. (1997) · The Journal of Infectious Diseases · doi:10.1086/516477 · Cited by 502
Hansman, D., & Bullen, M. M. (1967) · The Lancet · doi:10.1016/s0140-6736(67)92346-x · Cited by 499
Arason, V. A., Kristinsson, K. G., Sigurdsson, J. A., Stefansdottir, G., Molstad, S., & Gudmundsson, S. (1996) · BMJ · doi:10.1136/bmj.313.7054.387 · Cited by 492
Doern, G. V., Brueggemann, A., Holley, H. P., & Rauch, A. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1208 · Cited by 482
Population Snapshot of Emergent Streptococcus pneumoniae Serotype 19A in the United States, 2005
Moore, M. R., Gertz, Jr., Woodbury, R. L., Barkocy‐Gallagher, G. A., Schaffner, W., Lexau, C., Gershman, K., Reingold, A., Farley, M., Harrison, L. H., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/528996 · Cited by 480
Self-citationAntibiotic Stress Induces Genetic Transformability in the Human Pathogen Streptococcus pneumoniae
Prudhomme, M., Attaiech, L., Sanchez, G., Martin, B., & Claverys, J.-P. (2006) · Science · doi:10.1126/science.1127912 · Cited by 451
Da Cunha, V., Davies, M. R., Douarre, P.-E., Rosinski-Chupin, I., Margarit, I., Spinali, S., Perkins, T., Lechat, P., Dmytruk, N., Sauvage, E., et al. (2015) · Nature Communications · doi:10.1038/ncomms7108 · Cited by 437
Intercontinental Spread of a Multiresistant Clone of Serotype 23F Streptococcus pneumoniae
Munoz, R., Coffey, T. J., Daniels, M., Dowson, C. G., Laible, G., Casal, J., Hakenbeck, R., Jacobs, M., Musser, J. M., Spratt, B. G., et al. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/164.2.302 · Cited by 419
Dowson, C. G., Hutchison, A., Brannigan, J. A., George, R. C., Hansman, D., Liñares, J., Tomasz, A., Smith, J. M., & Spratt, B. G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8842 · Cited by 404
Doern, G. V., Pfaller, M. A., Kugler, K., Freeman, J., & Jones, R. N. (1998) · Clinical Infectious Diseases · doi:10.1086/514953 · Cited by 386
The Spread of Multiply Resistant Streptococcus pneumoniae at a Day Care Center in Ohio
Reichler, M. R., Allphin, A. A., Breiman, R. F., Schreiber, J. R., Arnold, J. E., McDougal, L. K., Facklam, R. R., Boxerbaum, B., May, D., Walton, R. O., et al. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.6.1346 · Cited by 376
Pallares, R., Gudiol, F., Liñares, J., Ariza, J., Rufi, G., Murgui, L., Dorca, J., & Viladrich, P. F. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707023170104 · Cited by 373
Emergence of vancomycin tolerance in Streptococcus pneumoniae
Novak, R., Henriques, B., Charpentier, E., Normark, S., & Tuomanen, E. (1999) · Nature · doi:10.1038/21202 · Cited by 346
Butler, J. C., Hofman, J., Cetron, M. S., Elliott, J. A., Facklam, R. R., Breiman, R. F., & Pneumococcal Sentinel Surveillance Working Group (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.5.986 · Cited by 341
Whole-genome sequencing to control antimicrobial resistance
Köser, C. U., Ellington, M. J., & Peacock, S. J. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.07.003 · Cited by 330
Pai, R., Moore, M. R., Pilishvili, T., Gertz, R. E., Whitney, C. G., Beall, B., & Active Bacterial Core Surveillance Team (2005) · The Journal of Infectious Diseases · doi:10.1086/498043 · Cited by 330
Self-citationCoffey, T. J., Dowson, C. G., Daniels, M., Zhou, J., Martin, C., Spratt, B. G., & Musser, J. M. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb02155.x · Cited by 314
Coffey, T. J., Enright, M. C., Daniels, M., Morona, J. K., Morona, R., Hryniewicz, W., Paton, J. C., & Spratt, B. G. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00658.x · Cited by 314
Antimicrobial Resistance to Linezolid
Meka, V. G., & Gold, H. S. (2004) · Clinical Infectious Diseases · doi:10.1086/423841 · Cited by 309
Doern, G. V., Ferraro, M. J., Brueggemann, A. B., & Ruoff, K. L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.891 · Cited by 297
Metlay, J. P., Hofmann, J., Cetron, M. S., Fine, M. J., Farley, M. M., Whitney, C., & Breiman, R. F. (2000) · Clinical Infectious Diseases · doi:10.1086/313716 · Cited by 270
Resistance to Macrolides and Related Antibiotics in Streptococcus pneumoniae
Leclercq, R., & Courvalin, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2727-2734.2002 · Cited by 269
Antimicrobial Resistance of Streptococcus pneumoniae in the United States, 1979-1987
Spika, J. S., Facklam, R. R., Plikaytis, B. D., Oxtoby, M. J., & Pneumococcal Surveillance Working Group (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.6.1273 · Cited by 261
Tait-Kamradt, A., Davies, T., Appelbaum, P. C., Depardieu, F., Courvalin, P., Petitpas, J., Wondrack, L., Walker, A., Jacobs, M. R., & Sutcliffe, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3395-3401.2000 · Cited by 260
Dowson, C. G., Coffey, T. J., Kell, C., & Whiley, R. A. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01723.x · Cited by 259
Streptococcus pneumoniae: Epidemiology, Risk Factors, and Strategies for Prevention
Lynch, J., & Zhanel, G. (2009) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0029-1202938 · Cited by 258
Song, J., Lee, N. Y., Ichiyama, S., Yoshida, R., Hirakata, Y., Fu, W., Chongthaleong, A., Aswapokee, N., Chiu, C., Lalitha, M. K., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514783 · Cited by 258
Feil, E. J., Smith, J. M., Enright, M. C., & Spratt, B. G. (2000) · Genetics · doi:10.1093/genetics/154.4.1439 · Cited by 250
Linares, J., Pallares, R., Alonso, T., Perez, J. L., Ayats, J., Gudiol, F., Viladrich, P. F., & Martin, R. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/15.1.99 · Cited by 248
Da Cunha, V., Davies, M. R., Douarre, P.-E., Rosinski-Chupin, I., Margarit, I., Spinali, S., Perkins, T., Lechat, P., Dmytruk, N., Sauvage, E., et al. (2014) · Nature Communications · doi:10.1038/ncomms5544 · Cited by 245
Grebe, T., & Hakenbeck, R. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.829 · Cited by 241
Breakthrough Pneumococcal Bacteremia in Patients Being Treated with Azithromycin and Clarithromycin
Kelley, M. A., Weber, D. J., Gilligan, P., & Cohen, M. S. (2000) · Clinical Infectious Diseases · doi:10.1086/318157 · Cited by 234
Janoir, C., Zeller, V, Kitzis, M. D., Moreau, N. J., & Gutmann, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.12.2760 · Cited by 232
Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978–1997
Mufson, M. A., & Stanek, R. J. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00098-4 · Cited by 227
McCormick, A. W., Whitney, C. G., Farley, M. M., Lynfield, R., Harrison, L. H., Bennett, N. M., Schaffner, W., Reingold, A., Hadler, J., Cieslak, P., et al. (2003) · Nature Medicine · doi:10.1038/nm839 · Cited by 222
Plouffe, J. F. (1996) · JAMA · doi:10.1001/jama.275.3.194 · Cited by 221
Chewapreecha, C., Marttinen, P., Croucher, N. J., Salter, S. J., Harris, S. R., Mather, A. E., Hanage, W. P., Goldblatt, D., Nosten, F. H., Turner, C., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004547 · Cited by 218
Nava, J. M., Bella, F., Garau, J., Lite, J., Morera, M.-A., Marti, C., Fontanals, D., Font, B., Pineda, V., Uriz, S., et al. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.5.884 · Cited by 215
Levine, O. S., Farley, M., Harrison, L. H., Lefkowitz, L., McGeer, A., Schwartz, B., & for the Active Bacterial Core Surveillance Team (1999) · Pediatrics · doi:10.1542/peds.103.3.e28 · Cited by 215
Gordon, E., Mouz, N., Duée, E., & Dideberg, O. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3740 · Cited by 213
Beall, B., McEllistrem, M. C., Gertz, R. E., Wedel, S., Boxrud, D. J., Gonzalez, A. L., Medina, M.-J., Pai, R., Thompson, T. A., Harrison, L. H., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.3.999-1017.2006 · Cited by 204
Self-citationMetcalf, B. J., Gertz, R. E., Gladstone, R. A., Walker, H., Sherwood, L. K., Jackson, D., Li, Z., Law, C., Hawkins, P. A., Chochua, S., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.08.027 · Cited by 203
Self-citationMuñoz, R., Dowson, C. G., Daniels, M., Coffey, T. J., Martin, C., Hakenbeck, R., & Spratt, B. G. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb01422.x · Cited by 193
Heterogeneity of tetracycline resistance determinants in Streptococcus
Burdett, V, Inamine, J., & Rajagopalan, S. (1982) · Journal of Bacteriology · doi:10.1128/jb.149.3.995-1004.1982 · Cited by 187
Munoz, R., Musser, J. M., Crain, M., Briles, D. E., Marton, A., Parkinson, A. J., Sørensen, U. B. S., & Tomasz, A. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/15.1.112 · Cited by 184
Molecular Mechanisms of β-Lactam Resistance in Streptococcus Pneumoniae
Hakenbeck, R., Brückner, R., Denapaite, D., & Maurer, P. (2012) · Future Microbiology · doi:10.2217/fmb.12.2 · Cited by 183
Pneumococcal Capsular Switching: A Historical Perspective
Wyres, K. L., Lambertsen, L. M., Croucher, N. J., McGee, L., von Gottberg, A., Linares, J., Jacobs, M. R., Kristinsson, K. G., Beall, B. W., Klugman, K. P., et al. (2013) · Journal of Infectious Diseases · doi:10.1093/infdis/jis703 · Cited by 182
Self-citationThe cost of antibiotic resistance from a bacterial perspective
Björkman, J., & Andersson, D. I. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0147 · Cited by 179
New molecular targets for the treatment of neutrophilic diseases
Barnes, P. J. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.01.015 · Cited by 177
Filipe, S. R., & Tomasz, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080067697 · Cited by 177
Tankovic, J., Perichon, B., Duval, J., & Courvalin, P. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2505 · Cited by 174
Control of cell division in Streptococcus pneumoniae by the conserved Ser/Thr protein kinase StkP
Beilharz, K., Nováková, L., Fadda, D., Branny, P., Massidda, O., & Veening, J.-W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119172109 · Cited by 172
Clavo‐Sanchez, A. J., Giron‐Gonzalez, J. A., Lopez‐Prieto, D., Canueto‐Quintero, J., Sanchez‐Porto, A., Vergara‐Campos, A., Marin‐Casanova, P., & Cordoba‐Dona, J. A. (1997) · Clinical Infectious Diseases · doi:10.1086/513628 · Cited by 172
Hakenbeck, R., König, A., Kern, I., van der Linden, M., Keck, W., Billot-Klein, D., Legrand, R., Schoot, B., & Gutmann, L. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.7.1831-1840.1998 · Cited by 170
Resistant pneumococci: protecting patients through judicious use of antibiotics.
Dowell, S. F., & Schwartz, B. (1997) · PubMed · Cited by 168
A Type IV Pilus Mediates DNA Binding during Natural Transformation in Streptococcus pneumoniae
Laurenceau, R., Péhau-Arnaudet, G., Baconnais, S., Gault, J., Malosse, C., Dujeancourt, A., Campo, N., Chamot-Rooke, J., Le Cam, E., Claverys, J.-P., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003473 · Cited by 168
Bedos, J.-P., Chevret, S., Chastang, C., Geslin, P., Regnier, B., & French Cooperative Pneumococcus Study Group (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.1.63 · Cited by 167
Hyper-Recombination, Diversity, and Antibiotic Resistance in Pneumococcus
Hanage, W. P., Fraser, C., Tang, J., Connor, T. R., & Corander, J. (2009) · Science · doi:10.1126/science.1171908 · Cited by 165
Wolter, N., Smith, A. M., Farrell, D. J., Schaffner, W., Moore, M. R., Whitney, C. G., Jorgensen, J. H., & Klugman, K. P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3554-3557.2005 · Cited by 165
Coffey, T. J., Daniels, M., McDougal, L. K., Dowson, C. G., Tenover, F. C., & Spratt, B. G. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1306 · Cited by 165
Garcia-Bustos, J., & Tomasz, A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5415 · Cited by 163
Tomczyk, S. M., Lynfield, R., Schaffner, W., Reingold, A. L., Miller, L. A., Petit, S., Holtzman, C., Zansky, S. M., Thomas, A. R., Baumbach, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw067 · Cited by 162
Self-citationSUSCEPTIBILITY OF PNEUMOCOCCI TO NINE ANTIBIOTICS
KISLAK, J. W., DALY, A. K., FINLAND, M., & LAWRENCE, M. B. R. (1965) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196509000-00003 · Cited by 161
Hakenbeck, R., Grebe, T., Zähner, D., & Stock, J. B. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01521.x · Cited by 161
Nasopharyngeal Carriage of Antibiotic-Resistant Pneumococci by Children in Group Day Care
Henderson, F. W., Gilligan, P. H., Wait, K. J., & Goff, D. A. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/157.2.256 · Cited by 157
Dowson, C. G., Hutchison, A., & Spratt, B. G. (1989) · Molecular Microbiology · doi:10.1111/j.1365-2958.1989.tb00108.x · Cited by 155
Differential Effects of Pneumococcal Vaccines against Serotypes 6A and 6C
Park, I. H., Moore, M. R., Treanor, J. J., Pelton, S. I., Pilishvili, T., Beall, B., Shelly, M., Mahon, B. E., Nahm, M. H., & Active Bacterial Core Surveillance Team (2008) · The Journal of Infectious Diseases · doi:10.1086/593339 · Cited by 154
Self-citationSibold, C., Henrichsen, J., König, A. A., Martin, C., Chalkley, L. J., & Hakenbeck, R. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb01089.x · Cited by 153
Fitness Costs of Fluoroquinolone Resistance in Streptococcus pneumoniae
Rozen, D. E., McGee, L., Levin, B. R., & Klugman, K. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01161-06 · Cited by 151
Self-citationAdrian, P. V., & Klugman, K. P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2406 · Cited by 149
TheStreptococcus pneumoniae ciaRegulon: CiaR Target Sites and Transcription Profile Analysis
Mascher, T., Zähner, D., Merai, M., Balmelle, N., de Saizieu, A., & Hakenbeck, R. (2002) · Journal of Bacteriology · doi:10.1128/jb.185.1.60-70.2003 · Cited by 149
Carvalho, M. D. G., Pimenta, F. C., Moura, I. S., Roundtree, A. V., Gertz, R. E., Li, Z., Jagero, G., Bigogo, G., Junghae, M., Conklin, L. M., et al. (2013) · PeerJ · doi:10.7717/peerj.97 · Cited by 147
Self-citationTurner, P., Turner, C. L., Jankhot, A., Helen, N., Lee, S. J., Day, N., White, N. J., Nosten, F. H., & Goldblatt, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038271 · Cited by 144
Clinical Outcomes of Bacteremic Pneumococcal Pneumonia in the Era of Antibiotic Resistance
Moroney, J. F., Fiore, A. E., Harrison, L. H., PATTERSON, J. E., Farley, M. M., Jorgensen, J. H., Phelan, M., Facklam, R. R., Cetron, M. S., Breiman, R. F., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/322623 · Cited by 144
Fluoroquinolone Resistance in Streptococcus pneumoniae in United States since 1994-1995
Brueggemann, A. B., Coffman, S. L., Rhomberg, P. R., Huynh, H. K., Almer, L. S., Nilius, A. M., Flamm, R. K., & Doern, G. V. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.680-688.2002 · Cited by 141
Croucher, N. J., Chewapreecha, C., Hanage, W. P., Harris, S. R., McGee, L., van der Linden, M., Song, J., Ko, K. S., de LENCASTRE, H., Turner, C., et al. (2014) · Genome Biology and Evolution · doi:10.1093/gbe/evu120 · Cited by 136
Self-citationMcCullers, J. A., English, B. K., & Novak, R. (2000) · The Journal of Infectious Diseases · doi:10.1086/315216 · Cited by 133
López, P., Espinosa, M., Greenberg, B., & Lacks, S. A. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.9.4320-4326.1987 · Cited by 132
Doherty, N., Trzciński, K., Pickerill, P., Zawadzki, P., & Dowson, C. G. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.2979-2984.2000 · Cited by 131
Prevention of Antibiotic-Nonsusceptible Streptococcus pneumoniae With Conjugate Vaccines
Hampton, L. M., Farley, M. M., Schaffner, W., Thomas, A. R., Reingold, A. L., Harrison, L. H., Lynfield, R., Bennett, N. M., Petit, S., Gershman, K. A., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir755 · Cited by 131
Self-citationGolubchik, T., Brueggemann, A. B., Street, T. L., Gertz, R. E., Spencer, C. C. A., Hồ, T., Giannoulatou, E., Link‐Gelles, R., Harding, R. M., Beall, B., et al. (2012) · Nature Genetics · doi:10.1038/ng.1072 · Cited by 129
Self-citationGertz, R. E., McEllistrem, M. C., Boxrud, D. J., Li, Z., Sakota, V., Thompson, T. A., Facklam, R. R., Besser, J. M., Harrison, L. H., Whitney, C. G., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.9.4194-4216.2003 · Cited by 127
Self-citationHanage, W. P., Huang, S. S., Lipsitch, M., Bishop, C., Godoy, D., Pelton, S. I., Goldstein, R., Huot, H., & Finkelstein, J. A. (2007) · The Journal of Infectious Diseases · doi:10.1086/510249 · Cited by 126
Carvalho, M. D. G., Pimenta, F. C., Gertz, R. E., Joshi, H. H., Trujillo, A. A., Keys, L. E., Findley, J., Moura, I. S., Park, I. H., Hollingshead, S. K., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01919-08 · Cited by 126
Self-citationTan, T. Q., Mason, E. O., & Kaplan, S. L. (1993) · PEDIATRICS · doi:10.1542/peds.92.6.761 · Cited by 118
Porat, N., Arguedas, A. G., Spratt, B. G., Trefler, R., Brilla, E., Loaiza, C., Godoy, D., Bilek, N., & Dagan, R. (2004) · The Journal of Infectious Diseases · doi:10.1086/425908 · Cited by 114
Pletz, M. W., McGee, L., Jorgensen, J. H., Beall, B., Facklam, R. R., Whitney, C. G., & Klugman, K. P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3491-3497.2004 · Cited by 112
Self-citationActive efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae
Zeller, V., Janoir, C., Kitzis, M.-D., Gutmann, L., & Moreau, N. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.1973 · Cited by 112
Hall, L. M. C., Whiley, R. A., Duke, B., George, R. C., & Efstratiou, A. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.4.853-859.1996 · Cited by 112
Felmingham, D., Cantón, R., & Jenkins, S. G. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.04.006 · Cited by 111
Shi, Z.-Y., Enright, M. C., Wilkinson, P., Griffiths, D., & Spratt, B. G. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.12.3514-3519.1998 · Cited by 110
Richter, S. S., Heilmann, K. P., Coffman, S. L., Huynh, H. K., Brueggemann, A. B., Pfaller, M. A., & Doern, G. V. (2002) · Clinical Infectious Diseases · doi:10.1086/338065 · Cited by 105
Crisóstomo, M. I., Vollmer, W., Kharat, A. S., Inhülsen, S., Gehre, F., Buckenmaier, S., & Tomasz, A. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05340.x · Cited by 105
Dagan, R., Barkai, G., Givon‐Lavi, N., Sharf, A., Vardy, D., Cohen, T., Lipsitch, M., & Greenberg, D. (2008) · The Journal of Infectious Diseases · doi:10.1086/528995 · Cited by 104
Draghi, D. C., Sheehan, D. J., Hogan, P. A., & Sahm, D. F. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.5024-5032.2005 · Cited by 102
Emergence of Streptococcus pneumoniae with Very-High-Level Resistance to Penicillin
Schrag, S. J., McGee, L., Whitney, C. G., Beall, B., Craig, A. S., Choate, M. E., Jorgensen, J. H., Facklam, R. R., & Klugman, K. P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3016-3023.2004 · Cited by 101
Self-citationFeng, J., Lupien, A., Gingras, H., Wasserscheid, J., Dewar, K., Légaré, D., & Ouellette, M. (2009) · Genome Research · doi:10.1101/gr.089342.108 · Cited by 100
Balsalobre, L., Ferrándiz, M.-J., Liñares, J., Tubau, F., & de la Campa, A. G. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2072-2081.2003 · Cited by 100
Penicillin Tolerance in Multiply Drug-Resistant Natural Isolates of Streptococcus pneumoniae
Liu, H. H., & Tomasz, A. (1985) · The Journal of Infectious Diseases · doi:10.1093/infdis/152.2.365 · Cited by 95
Berg, K. H., Stamsås, G. A., Straume, D., & Håvarstein, L. S. (2013) · Journal of Bacteriology · doi:10.1128/jb.00184-13 · Cited by 95
Interaction of Non-lytic -Lactams with Penicillin-binding Proteins in Streptococcus pneumoniae
Hakenbeck, R., Tornette, S., & Adkinson, N. F. (1987) · Microbiology · doi:10.1099/00221287-133-3-755 · Cited by 94
Pneumococcal Carriage and Antibiotic Resistance in Young Children Before 13-valent Conjugate Vaccine
Wroe, P. C., Lee, G. M., Finkelstein, J. A., Pelton, S. I., Hanage, W. P., Lipsitch, M., Stevenson, A. E., Rifas‐Shiman, S. L., Kleinman, K., Dutta-Linn, M. M., et al. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31824214ac · Cited by 93
Gherardi, G., Whitney, C. G., Facklam, R. R., & Beall, B. (2000) · The Journal of Infectious Diseases · doi:10.1086/315194 · Cited by 93
Self-citationContreras‐Martel, C., Job, V., Guilmi, A. M. D., Vernet, T., Dideberg, O., & Dessen, A. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.10.030 · Cited by 92
Feikin, D. R., Dowell, S. F., Nwanyanwu, O. C., Klugman, K. P., Kazembe, P. N., Barat, L. M., Graf, C., Bloland, P. B., Ziba, C., Huebner, R. E., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315382 · Cited by 92
Santagati, M., Iannelli, F., Cascone, C., Campanile, F., Oggioni, M. R., Stefani, S., & Pozzi, G. (2003) · Microbial Drug Resistance · doi:10.1089/107662903322286445 · Cited by 91
Mutations in the Active Site of Penicillin-binding Protein PBP2x from Streptococcus pneumoniae
Mouz, N., Guilmi, A. M. D., Gordon, E. J., Hakenbeck, R., Dideberg, O., & Vernet, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19175 · Cited by 91
McDougal, L. K., Rasheed, J. K., Biddle, J. W., & Tenover, F. C. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2282 · Cited by 91
Smith, A. M., & Klugman, K. P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.8.2393-2396.2001 · Cited by 91
Sharma, D., Baughman, W., Holst, A., Thomas, S., Jackson, D. M., Carvalho, M. D. G., Beall, B., Satola, S. W., Jerris, R. R., Jain, S., et al. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182788fdd · Cited by 89
Self-citation(2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31819b563f · Cited by 88
Pernot, L., Chesnel, L., Gouëllec, A. L., Croizé, J., Vernet, T., Dideberg, O., & Dessen, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313492200 · Cited by 87
Tedizolid: A new oxazolidinone antimicrobial
Kisgen, J. J., Mansour, H., Unger, N. R., & Childs, L. M. (2014) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp130482 · Cited by 86
Sigurdur Einarsson, M. K. (1998) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365549850160882 · Cited by 86
Colonization of Mucosal Surfaces
(2005) · ASM Press eBooks · doi:10.1128/9781555817619 · Cited by 85
Orio, A. G. A., Piñas, G. E., Cortes, P. R., Cian, M. B., & Echenique, J. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002000 · Cited by 85
PBP Active Site Flexibility as the Key Mechanism for β-Lactam Resistance in Pneumococci
Contreras‐Martel, C., Dahout-Gonzalez, C., Martins, A. D. S., Kotnik, M., & Dessen, A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.02.024 · Cited by 85
Weigel, L. M., Anderson, G. J., Facklam, R. R., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3517-3523.2001 · Cited by 84
Kell, C. M., Sharma, U. K., Dowson, C. G., Town, C., Balganesh, T. S., & Spratt, B. G. (1993) · FEMS Microbiology Letters · doi:10.1016/0378-1097(93)90076-e · Cited by 83
Enright, M. C., & Spratt, B. G. (1999) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a026082 · Cited by 82
Navarro-Torné, A., Dias, J. G., Quinten, C., Hruba, F., Busana, M. C., Lopalco, P. L., Amato‐Gauci, A. J., & Celentano, L. P. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.04.066 · Cited by 81
Farrell, D. J., Morrissey, I., Bakker, S., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3169-3171.2004 · Cited by 80
The Tetracycline Resistance Genetet(M) Exhibits Mosaic Structure
Oggioni, M. R., Dowson, C. G., Smith, J. M., Provvedi, R., & Pozzi, G. (1996) · Plasmid · doi:10.1006/plas.1996.0018 · Cited by 79
Edman, M., Berg, S., Storm, P., Wikström, M., Vikström, S., Öhman, A., & Wieslander, Å. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211492200 · Cited by 78
Chen, Y., Deng, W., Wang, S., Mo, Q.-M., Jia, H., Wang, Q., Li, S.-G., Li, X., Yao, B., Liu, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027333 · Cited by 78
Morlot, C., Bayle, L.-D., Jacq, M., Fleurie, A., Tourcier, G., Galisson, F., Vernet, T., Grangeasse, C., & Guilmi, A. M. D. (2013) · Molecular Microbiology · doi:10.1111/mmi.12348 · Cited by 77
Mechanism of sulfonamide resistance in clinical isolates of Streptococcus pneumoniae
Maskell, J. P., Sefton, A. M., & Hall, L. M. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2121 · Cited by 75
On the specificity of antibiotics targeting the large ribosomal subunit
Wilson, D. N. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06192.x · Cited by 73
Janoir, C., Podglajen, I., Kitzis, M.-D., Poyart, C., & Gutmann, L. (1999) · The Journal of Infectious Diseases · doi:10.1086/314888 · Cited by 72
Sham, L., Tsui, H. T., Land, A. D., Barendt, S. M., & Winkler, M. E. (2012) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.12.013 · Cited by 70
Rieux, V., Carbon, C., & Azoulay-Dupuis, E. (2001) · The Journal of Infectious Diseases · doi:10.1086/320992 · Cited by 67
dos Santos, S. R., Passadore, L. F., Takagi, E. H., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.05.042 · Cited by 66
Linezolid Surveillance Results for the United States: LEADER Surveillance Program 2011
Flamm, R. K., Mendes, R. E., Ross, J. E., Sader, H. S., & Jones, R. N. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02112-12 · Cited by 66
Trzciński, K., Thompson, C. M., Gilbey, A. M., Dowson, C. G., & Lipsitch, M. (2006) · The Journal of Infectious Diseases · doi:10.1086/501367 · Cited by 64
Ruhe, J., & Hasbun, R. (2003) · Clinical Infectious Diseases · doi:10.1086/374556 · Cited by 62
Antimicrobial-resistantStreptococcus pneumoniae: trends and management
Jacobs, M. R. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.619 · Cited by 62
Cochetti, I., Vecchi, M., Mingoia, M., Tili, E., Catania, M. R., Manzin, A., Varaldo, P. E., & Montanari, M. P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4999-5006.2005 · Cited by 61
Penicillin-Binding Proteins 2x and 2b as Primary PBP Targets in Streptococcus pneumoniae
Krauss, J. B., van der Linden, M., Grebe, T. W., & Hakenbeck, R. (1996) · Microbial Drug Resistance · doi:10.1089/mdr.1996.2.183 · Cited by 59
Identification of the tetracycline resistance gene, tet(O), in Streptococcus pneumoniae
Widdowson, C. A., Klugman, K. P., & Hanslo, D. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.12.2891 · Cited by 59
An international activity and spectrum analysis of linezolid: ZAAPS Program results for 2011
Flamm, R. K., Mendes, R. E., Ross, J. E., Sader, H. S., & Jones, R. N. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.01.025 · Cited by 58
Vallès, X., Flannery, B. L., Roca, A., Mandomando, I., Sigaúque, B., Sanz, S., Schuchat, A., Levine, M. M., Soriano-Gabarró, M., & Alonso, P. L. (2006) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01565.x · Cited by 57
Padayachee, T., & Klugman, K. P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.9.2225 · Cited by 56
Grebe, T., Paik, J., & Hakenbeck, R. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.10.3342-3349.1997 · Cited by 56
Brandileone, M. C. C., Casagrande, S. T., Guerra, M.-L. L. S., Zanella, R. C., de Andrade, A.-L. S. S., & Fábio, J. L. D. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46387-0 · Cited by 55
Chesnel, L., Carapito, R., Croizé, J., Dideberg, O., Vernet, T., & Zapun, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2895-2902.2005 · Cited by 54
Reynolds, C. A., Finkelstein, J. A., Ray, G. T., Moore, M. R., & Huang, S. S. (2014) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-3-16 · Cited by 52
Balsalobre, L., & de la Campa, A. G. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00731-07 · Cited by 51
Sauerbier, J., Maurer, P., Rieger, M., & Hakenbeck, R. (2012) · Molecular Microbiology · doi:10.1111/mmi.12009 · Cited by 50
Dual activity of fluoroquinolones against Streptococcus pneumoniae: the facts behind the claims
Smith, H. J. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf047 · Cited by 47
Mingoia, M., Vecchi, M., Cochetti, I., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00790-07 · Cited by 46
Filipe, S. R., Severina, E. P., & Tomasz, A. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.23.6798-6805.2000 · Cited by 45
Wyres, K. L., van Tonder, A. J., Lambertsen, L. M., Hakenbeck, R., Parkhill, J., Bentley, S. D., & Brueggemann, A. B. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-500 · Cited by 45
STUDIES ON INDUCED RESISTANCE TO PENICILLIN IN A PNEUMOCOCCUS TYPE I*
Eriksen, K. R. (1945) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1945.tb04075.x · Cited by 43
Ho, P., Yam, W. C., Cheung, T. K. M., Ng, W. W., Que, T. L., Tsang, D. N. C., Ng, T. K., & Seto, W. (2001) · Emerging infectious diseases · doi:10.3201/eid0705.010526 · Cited by 41
Eldere, J. V., Mera, R. M., Miller, L. A., Poupard, J. A., & Amrine‐Madsen, H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01581-06 · Cited by 40
Harris, K., Turner, P., Cloutman-Green, E., & Hartley, J. C. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02462-07 · Cited by 39
New insights into pneumococcal disease
Feldman, C. H., & Anderson, R. (2008) · Respirology · doi:10.1111/j.1440-1843.2008.01422.x · Cited by 38
PNEUMOCOCCAL MENINGITIS DURING THERAPY OF OTITIS MEDIA WITH CLARITHROMYCIN
Reid, R. T., Bradley, J. S., & Hindler, J. A. (1995) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199512000-00016 · Cited by 38
Parra-Barrera, E. L., de la Hoz, F., Díaz, P., Sanabria, O. M., Realpe, M. E., & Moreno, J. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.04.074 · Cited by 38
Tolerance to the Glycopeptides Vancomycin and Teicoplanin in Coagulase-Negative Staphylococci
Bourgeois, I., Pestel‐Caron, M., Lemeland, J., Pons, J.-L., & Caron, F. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00719-06 · Cited by 38
Dhoubhadel, B. G., Yasunami, M., Nguyen, H. A. T., Suzuki, M., Vu, T. H., Nguyen, A. T. T., Dang, D. A., Yoshida, L., & Ariyoshi, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110777 · Cited by 38
Dias, R. P. M., Félix, D., Caniça, M., & Trombe, M. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-121 · Cited by 37
Katsarolis, I., Poulakou, G., Analitis, A., Matthaiopoulou, I., Roilides, E., Antachopoulos, C., Kafetzis, D., Daikos, G. L., Vorou, R., Koubaniou, C., et al. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-120 · Cited by 36
Genetic Characterization of Optochin-Susceptible Viridans Group Streptococci
Martín-Galiano, A. J., Balsalobre, L., Fenoll, A., & de la Campa, A. G. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3187-3194.2003 · Cited by 33
Pai, R. B., Gertz, R. E., Whitney, C. G., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.11.5440-5444.2005 · Cited by 30
Müller, M. J., Marx, P., Hakenbeck, R., & Brückner, R. (2011) · Microbiology · doi:10.1099/mic.0.053157-0 · Cited by 30
Bast, D. J., de Azavedo, J. C. S., Tam, T. Y., Kilburn, L., Duncan, C. L., Mandell, L. A., Davidson, R., & Low, D. E. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2631-2634.2001 · Cited by 29
Crowther-Gibson, P., Cohen, C., Klugman, K. P., de Gouveia, L., & von Gottberg, A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06463-11 · Cited by 29
Rethinking Replacement and Resistance
Moore, M. R. (2009) · The Journal of Infectious Diseases · doi:10.1086/597045 · Cited by 29
Baylay, A. J., Ivens, A. C., & Piddock, L. J. V. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04858-14 · Cited by 27
Cited by
Troeger, C., Blacker, B., Khalil, I. A., Rao, P. C., Cao, J., Zimsen, S. R. M., Albertson, S. B., Deshpande, A., Farag, T., Abebe, Z., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30310-4 · Cited by 1,968
Troeger, C., Forouzanfar, M., Rao, P. C., Khalil, I., Brown, A., Swartz, S., Fullman, N., Mosser, J., Thompson, R. L., Reiner, R. C., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30396-1 · Cited by 764
Balsells, E., Guillot, L., Nair, H., & Kyaw, M. H. (2017) · PLOS ONE · doi:10.1371/journal.pone.0177113 · Cited by 393
Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming Approaches
Jubeh, B., Breijyeh, Z., & Karaman, R. (2020) · Molecules · doi:10.3390/molecules25122888 · Cited by 383
Streptococcus pneumoniae’s Virulence and Host Immunity: Aging, Diagnostics, and Prevention
Brooks, L. R. K., & Mias, G. I. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01366 · Cited by 286
Metadata
- Authors
- Kim, L., McGee, L., Tomczyk, S., & Beall, B.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2016-07
- Volume
- 29
- Issue
- 3
- Pages
- 525-552
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2341199367
- Cited by
- 285
- References
- 215
- FWCI
- 26.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.